Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.23 USD | +2.72% | -2.64% | -9.58% |
15/05 | HC Wainwright Adjusts Price Target on REGENXBIO to $38 From $36, Maintains Buy Rating | MT |
09/05 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.58% | 778M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Wedbush Lifts REGENXBIO's PT to $21 From $20 After Higher-Than-Expected Q3 Revenue, Announced Restructuring; Keeps Neutral Rating